Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD).
Ruth B SchneiderLarsson OmbergEric A MacklinMargaret DaeschlerLauren BatailleShalini AnthwalTaylor L MyersElizabeth BalogaSidney DuquettePhil SnyderKatherine AmodeoChristopher G TarolliJamie L AdamsKatherine F CallahanJoshua GottesmanCatherine M KopilCodrin LunguAlberto AscherioJames C BeckKevin BiglanAlberto J EspayCaroline TannerDavid OakesIra ShoulsonDan NovakElise KaysonEarl Ray DorseyLara MangraviteMichael A SchwarzschildTanya Simuninull nullPublished in: Annals of clinical and translational neurology (2020)
It is feasible to conduct a large-scale, international virtual observational study following the completion of participation in brick-and-mortar clinical trials in Parkinson's disease. This study, which brings research to participants, will compare established clinical endpoints with novel digital biomarkers and thereby inform the longitudinal follow-up of clinical trial participants and design of future clinical trials.